Aptium Oncology Inc is categorized under Specialty Outpatient Clinics, Nec in New York City, NY .
Aptium Oncology Inc was established in 0, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Specialty Outpatient Clinics, Nec business, which does work in the B2C market, and is classified as a Specialty Outpatient Clinics, Nec, under code number 6219992 by the NAICS.
If you are seeking more information, feel free to contact Peter H Jessup at the company’s branch by writing to 160 East 32nd St, New York City, New York NY 10016 or by phoning (212) 652-1900. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Aptium Oncology Inc |
| Contact Person: | Peter H Jessup |
| Address: | 160 East 32nd St, New York City, New York 10016 |
| Phone Number: | (212) 652-1900 |
| Website Address: | aptiumoncology.com |
| Annual Revenue (USD): | $5.000.000 to $9.999.999 |
| Location Type: | Branch |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Specialty Outpatient Clinics, Nec |
| SIC Code: | 8093 |
| NAICS Code: | 6219992 |
| Share This Business: |
Aptium Oncology Inc was started in 0 to provide professional Specialty Outpatient Clinics, Nec under the SIC code 8093 and NAICS code 6219992. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact Peter H Jessup for inquiries that concern Aptium Oncology Inc by calling the company number (212) 652-1900, as your correspondence is most welcome. Additionally, the physical location of the branch of Aptium Oncology Inc can be found at the coordinates 40.74449,-73.97929 as well as the street address 160 East 32nd St in New York City, New York 10016.
For its online presence, you may visit Aptium Oncology Inc’s website at aptiumoncology.com and engage with its social media outlets through on Twitter and on Facebook.